Question 1

Is Solavia using the same Dana-Farber oncology pathways content as before?

Accepted Answer

Yes. Solavia continues to use the same evidence-based oncology pathways developed in partnership with Dana-Farber Cancer Institute. The content, curation process, and clinical rigor remain unchanged.

Question 2

Who creates and maintains Solavia's oncology pathways?

Accepted Answer

Solavia’s pathways are developed and maintained by a multidisciplinary team of oncology experts in collaboration with leading academic cancer centers, overseen by the Dana-Farber Cancer Institute.

Question 3

How does Solavia integrate into the clinician's workflow?

Accepted Answer

Solavia integrates directly with your EHR system, allowing clinicians to launch the platform from within the patient record without switching applications or re-entering data.

Question 4

How often are the pathways updated?

Accepted Answer

Expert multi-institutional pathways committees are scheduled to meet 2-4 times/year for each disease to review new FDA actions, publications, presentations and system usage data. In addition, committees meet on an ad hoc basis to address urgent game-changing developments that should not wait until a scheduled meeting.

Question 5

How does Solavia incorporate the latest evidence, guidelines, and clinical trials?

Accepted Answer

Our clinical content team monitors FDA actions, major presentations, and the peer-reviewed literature continuously. New evidence is evaluated, reviewed by clinical experts, and incorporated into pathways through a structured update process.

Question 6

How are pathways validated and reviewed?

Accepted Answer

All pathways undergo a rigorous multi-step review process involving oncology specialists, clinical pharmacists, and evidence-based medicine experts before publication.

Question 7

How does Solavia support shared decision-making with patients?

Accepted Answer

Solavia generates patient-ready materials including treatment summaries and consent forms that clinicians can use to facilitate informed conversations with patients about their care options.

Question 8

At what points in the care pathway is Solavia designed to be used (e.g., initial diagnosis, tumor board, treatment changes)?

Accepted Answer

Solavia is designed to support clinicians at multiple touchpoints: initial diagnosis and staging, tumor board preparation, treatment selection, and ongoing treatment monitoring and changes.

Question 9

How long does it typically take to use Solavia during a visit?

Accepted Answer

Most clinicians complete pathway navigation in under two minutes. Solavia is designed to support clinical decision-making efficiently, helping integrate evidence-based guidance into the visit without disrupting workflow.

Question 10

How long does implementation typically take?

Accepted Answer

Implementation timelines vary based on EHR complexity and institutional requirements, but most health systems go live within 8–12 weeks of contract signing.

Question 11

What training and onboarding support is provided?

Accepted Answer

Solavia provides comprehensive onboarding including live training sessions, on-demand video resources, and dedicated customer success support throughout the implementation and go-live period.

Question 12

Which cancer types and tumor boards are covered?

Accepted Answer

Solavia covers a broad range of solid tumors and hematologic malignancies, including breast, lung, colorectal, prostate, and hematologic cancers. Coverage is continuously expanding based on clinical need and partner input.

Question 13

Will my existing integrations and configurations carry over?

Accepted Answer

Yes. Existing EHR integrations, institutional customizations, and configurations will be migrated to the Solavia platform as part of the transition process.

Question 14

Are clinical trials surfaced within the pathway recommendations?

Accepted Answer

Yes. Relevant clinical trials available at your institution are surfaced within pathway recommendations, making it easy for clinicians to identify and discuss trial eligibility with patients.

Question 15

Does Solavia support analytics and reporting for administrators?

Accepted Answer

Yes. Solavia provides administrators with dashboards and reports on pathway adherence, treatment variation, and outcomes data, supporting quality initiatives and reimbursement reporting.

Question 16

Can Solavia generate patient-facing materials?

Accepted Answer

Yes. Solavia can generate patient-ready treatment summaries and consent forms directly from the pathway session, reducing administrative burden and supporting informed consent workflows.

Question 17

Which EHR systems does Solavia integrate with?

Accepted Answer

Solavia integrates with major EHR platforms including Epic, Cerner, and others via HL7 FHIR standards. Contact us to discuss your specific EHR environment.

Question 18

Is Solavia HIPAA compliant and how is data secured?

Accepted Answer

Yes. Solavia is fully HIPAA compliant. Data is encrypted in transit and at rest, access is role-based, and the platform undergoes regular security audits and penetration testing.